Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
This study is ongoing, but not recruiting participants.
First Received: September 13, 2005   Last Updated: October 17, 2006   History of Changes
Sponsors and Collaborators: Bayside Health
University of Melbourne
Information provided by: Bayside Health
ClinicalTrials.gov Identifier: NCT00164138
  Purpose

Women with chronic lung disease characterised by chronic cough report urinary incontinence. Recently there have been reports of increased urinary incontinence in girls and women with cystic fibrosis. While coughing is a known risk factor for stress incontinence, other risk factors and causes are poorly understood in this population. Treatment of incontinence for patients with chronic lung disease is also poorly addressed, adding to the burden of disease for women with chronic lung disease, carers and the health system. This project will estimate the prevalence of women with CF and COPD compared to healthy age matched controls and will evaluate the effect of a specific treatment and management program for these patients. The results will be disseminated to respiratory health professionals. We hypothesise that women with chronic cough will have a higher incidence of urinary incontinence than healthy controls and that a specific treatment program will result in alleviation of the problems and improved quality of life.


Condition Intervention
Cystic Fibrosis
Chronic Obstructive Pulmonary Disease (COPD)
Procedure: Pelvic floor muscle training, biofeedback, electrotherapy, bladder training

Genetics Home Reference related topics: cystic fibrosis
MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease) Cough Cystic Fibrosis Pelvic Support Problems Urinary Incontinence
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study
Official Title: Development of an Intervention and and Education Program for Adult Women With Urinary Incontinence and Chronic Lung Disease Including Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)

Further study details as provided by Bayside Health:

Primary Outcome Measures:
  • Symptom measures:
  • 3-day frequency volume chart,
  • 24 hour pad weigh test,
  • accident diary,
  • quality of life using King's Health Questionnaire.
  • pelvic floor muscle function:
  • Trans-abdominal diagnostic ultra-sound
  • EMG study of the pelvic floor muscles

Estimated Enrollment: 180
Study Start Date: December 2001
Estimated Study Completion Date: December 2006
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: - Women with CF and COPD Exclusion Criteria: -

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00164138

Locations
Australia, Victoria
The Alfred Hospital
Melbourne, Victoria, Australia, 3004
School of Physiotherapy, The University of Melbourne
Melbourne, Victoria, Australia, 3052
Sponsors and Collaborators
Bayside Health
University of Melbourne
Investigators
Principal Investigator: Brenda M Button, DPhty, PhD The Alfred Hospital, Melbourne
Study Director: John W Wilson, MBBS, PhD The Alfred Hospital, Melbourne
  More Information

No publications provided

Study ID Numbers: 108/01, Dept. of Health and Aged Care
Study First Received: September 13, 2005
Last Updated: October 17, 2006
ClinicalTrials.gov Identifier: NCT00164138     History of Changes
Health Authority: Australia: National Health and Medical Research Council

Keywords provided by Bayside Health:
Incontinence, physiotherapy, treatment, pelvic floor muscle function, coughing, forced expirations, lung disease

Study placed in the following topic categories:
Urination Disorders
Fibrosis
Respiration Disorders
Cough
Signs and Symptoms
Lung Diseases, Obstructive
Digestive System Diseases
Urologic Diseases
Cystic Fibrosis
Respiratory Tract Diseases
Genetic Diseases, Inborn
Lung Diseases
Pancreatic Diseases
Infant, Newborn, Diseases
Urinary Incontinence
Pulmonary Disease, Chronic Obstructive

Additional relevant MeSH terms:
Urination Disorders
Fibrosis
Respiration Disorders
Signs and Symptoms
Urological Manifestations
Lung Diseases, Obstructive
Digestive System Diseases
Pathologic Processes
Urologic Diseases
Cystic Fibrosis
Respiratory Tract Diseases
Genetic Diseases, Inborn
Lung Diseases
Pancreatic Diseases
Infant, Newborn, Diseases
Urinary Incontinence
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on May 06, 2009